The Goldman Sachs Group, Inc.
NYSE:GSFinancial - Capital Markets
+$2.40 today
- Market cap
- $251.86B
- Beta
- 1.29
- P/E (TTM)
- 18.5
- EPS (TTM)
- $59.47
- Dividend yield
- 1.54%
Volume 1.84M
Average 2.09M
GS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
The Goldman Sachs Group, Inc.NYSE: GS
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How GS compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for GS, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | ¥0 JPY | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Aug 2026 | -$221.52M USD | -174.6% | — | 1.8% | |
| Peer median (excluding GS) | — | -174.6% | — | 0.0% | |
Competitors are the stored peer set for GS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 64.99B | 68.71B | 108.42B | 126.85B | 125.1B |
| Cost of Revenue | 6.01B | 24.06B | 63.19B | 74.69B | 65.7B |
| Gross Profit | 58.98B | 44.65B | 45.23B | 52.16B | 59.4B |
| Gross Margin | 90.8% | 65.0% | 41.7% | 41.1% | 47.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 18.27B | 15.96B | 16.13B | 17.35B | 19.62B |
| Operating Expenses | 31.94B | 31.16B | 34.49B | 33.77B | 37.54B |
| Depreciation & Amortization | 2.02B | 2.46B | 4.86B | 2.39B | 2.18B |
| EBITDA | 29.06B | 15.94B | 15.6B | 20.79B | 24.03B |
| EBITDA Margin | 44.7% | 23.2% | 14.4% | 16.4% | 19.2% |
| Operating Income | 27.04B | 13.49B | 10.74B | 18.4B | 21.85B |
| Operating Margin | 41.6% | 19.6% | 9.9% | 14.5% | 17.5% |
| Interest Income | 12.12B | 29.02B | 68.52B | 81.4B | 80.37B |
| Interest Expense | 5.65B | 21.35B | 62.16B | 73.34B | 66.81B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 27.04B | 13.49B | 10.74B | 18.4B | 21.85B |
| Pre-Tax Margin | 41.6% | 19.6% | 9.9% | 14.5% | 17.5% |
| Income Tax Expense | 5.41B | 2.23B | 2.22B | 4.12B | 4.68B |
| Net Income | 21.64B | 11.26B | 8.52B | 14.28B | 17.18B |
| Net Margin | 33.3% | 16.4% | 7.9% | 11.3% | 13.7% |
| EPS (Basic) | 60.35 | 30.57 | 23.05 | 41.22 | 51.95 |
| EPS (Diluted) | 59.45 | 30.06 | 22.87 | 40.54 | 51.32 |
| Weighted Avg Shares | 350.5M | 352.1M | 340.8M | 328.1M | 312.7M |
| Weighted Avg Shares (Diluted) | 355.8M | 358.1M | 345.8M | 333.6M | 317.6M |
The Goldman Sachs Group, Inc.
NYSE:GS
Intrinsic Alpha fair value
Locked
Current Price
$873.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.